Are Institutions Heavily Invested In Frazier Lifesciences Acquisition Corporation's (NASDAQ:FLAC) Shares?

The big shareholder groups in Frazier Lifesciences Acquisition Corporation (NASDAQ:FLAC) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies. Companies that have been privatized tend to have low insider ownership.

Frazier Lifesciences Acquisition is not a large company by global standards. It has a market capitalization of US$176m, which means it wouldn't have the attention of many institutional investors. Our analysis of the ownership of the company, below, shows that institutions own shares in the company. Let's take a closer look to see what the different types of shareholders can tell us about Frazier Lifesciences Acquisition.

View our latest analysis for Frazier Lifesciences Acquisition

ownership-breakdown
NasdaqCM:FLAC Ownership Breakdown July 24th 2022

What Does The Institutional Ownership Tell Us About Frazier Lifesciences Acquisition?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

As you can see, institutional investors have a fair amount of stake in Frazier Lifesciences Acquisition. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Frazier Lifesciences Acquisition, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
NasdaqCM:FLAC Earnings and Revenue Growth July 24th 2022

Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. Frazier Lifesciences Acquisition is not owned by hedge funds. The company's largest shareholder is Frazier Lifesciences Sponsor LLC, with ownership of 19%. Alyeska Investment Group, L.P. is the second largest shareholder owning 4.2% of common stock, and D. E. Shaw & Co., L.P. holds about 4.0% of the company stock.

After doing some more digging, we found that the top 13 have the combined ownership of 52% in the company, suggesting that no single shareholder has significant control over the company.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.